Publication | Closed Access
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma
26
Citations
8
References
2011
Year
Cnto 95Dose LevelsMedicineMelanomaImmune Checkpoint InhibitorPharmacotherapyDermatologyPharmacologic EvaluationImmunotherapyOncologyCancer Treatment
| Year | Citations | |
|---|---|---|
Page 1
Page 1